Stockholm Medtech Growth (SMG)
STING participate in a 3-year EU project to help the Swedish medtech companies with its internationalization. It takes place within the framework of the EU project Stockholm Medtech Growth (SMG).
Stockholm Medtech Growth (SMG) is a cooperation project between The Center for Technology and Health (CTMH), Danderyd Hospital Innovation (DSI), Karolinska Trial Alliance (KTA), Stockholm Business Region Development (SBRD), Invest in Sweden Agency (ISA), Stockholm Innovation & Growth (STING) and Stockholm Uppsala Life Science (SULS) in order to strengthen the competitiveness of Swedish Medical Device Companies in a international perspective and to establish Stockholm as the leading centre of Medical Technology of northern Europe. The project is financed by EU through the Swedish Agency for Economic and Regional Growth.
